Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Total Current Liabilities: 2018-2024

Historic Total Current Liabilities for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to $67.2 million.

  • Bicycle Therapeutics' Total Current Liabilities rose 22.83% to $69.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 22.83%. This contributed to the annual value of $67.2 million for FY2024, which is 3.32% down from last year.
  • Bicycle Therapeutics' Total Current Liabilities amounted to $67.2 million in FY2024, which was down 3.32% from $69.5 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Total Current Liabilities ranged from a high of $69.5 million in FY2023 and a low of $23.1 million during FY2020.
  • For the 3-year period, Bicycle Therapeutics' Total Current Liabilities averaged around $63.4 million, with its median value being $67.2 million (2024).
  • As far as peak fluctuations go, Bicycle Therapeutics' Total Current Liabilities spiked by 162.20% in 2020, and later dropped by 3.32% in 2024.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Total Current Liabilities stood at $23.1 million in 2020, then spiked by 56.68% to $36.2 million in 2021, then surged by 47.20% to $53.3 million in 2022, then spiked by 30.36% to $69.5 million in 2023, then declined by 3.32% to $67.2 million in 2024.